ストックスクリーナーアプリを入手
1.57
0.64%
0.01
前日終値:
$1.56
開ける：
$1.52
24時間の取引高:
812.93K
Relative Volume:
0.18
時価総額：
$3.55M
収益：
$54.43M
当期純損益:
$-36.70M
株価収益率:
-0.5352
EPS:
-2.9334
ネットキャッシュフロー:
$-19.17M
1週間 パフォーマンス:
-3.09%
1か月 パフォーマンス:
+118.06%
6か月 パフォーマンス:
+104.32%
1年 パフォーマンス:
-29.60%
1日の値動き範囲:
$1.51
$1.67
1週間の範囲:
$1.34
$1.97
52週間の値動き範囲:
$0.48
$3.44
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
TRIB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
1.57 | 29.25M | 54.43M | -36.70M | -19.17M | -2.9334 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-10-23 | ダウングレード | Craig Hallum | Buy → Hold |
| 2015-09-03 | 開始されました | Raymond James | Outperform |
| 2015-07-29 | 繰り返されました | ROTH Capital | Buy |
| 2008-07-22 | 繰り返されました | Roth Capital | Buy |
| 2008-03-17 | 繰り返されました | Roth Capital | Buy |
| 2007-12-10 | 繰り返されました | Roth Capital | Buy |
| 2007-10-26 | 繰り返されました | Roth Capital | Buy |
すべてを表示
Trinity Biotech Plc Adr (TRIB) 最新ニュース
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
TRIB’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com India
Trinity Biotech receives NY approval for preeclampsia test - Investing.com
Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service - GlobeNewswire Inc.
Trinity Biotech stock rises on successful CGM calibration-free trial By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on successful CGM calibration-free trial - Investing.com India
Trinity Biotech reports positive results for calibration-free CGM By Investing.com - Investing.com South Africa
Trinity Biotech reports positive results for calibration-free CGM - Investing.com India
Trinity Biotech (TRIB) to Release Earnings on Wednesday - Defense World
Trinity Biotech launches preeclampsia testing service for maternal health By Investing.com - Investing.com South Africa
Trinity Biotech launches preeclampsia testing service for maternal health - Investing.com India
Trinity Biotech Plc Sponsored ADR Class A to Host Earnings Call - ACCESS Newswire
Cadence Bank (CADE) Stock: A Year of Market Fluctuations - investchronicle.com
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com India
Trinity Biotech stock hits 52-week low at $0.62 amid challenges - Investing.com
Trinity Biotech (NASDAQ:TRIB) Research Coverage Started at StockNews.com - Armenian Reporter
Trinity Biotech stock hits 52-week low at $0.72 amid challenges By Investing.com - Investing.com South Africa
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech secures amended credit to fuel growth By Investing.com - Investing.com South Africa
Trinity Biotech secures amended credit to fuel growth - Investing.com India
Trinity Biotech secures $4m for CGM technology growth - Investing.com
Trinity Biotech Secures Additional $4 Million in Debt Financing to Advance Continuous Glucose Monitoring Technology and Transformation Plan - Nasdaq
Investor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call - ACCESS Newswire
TRIBTrinity Biotech Announces Quarter 1 Financial Results - br.ADVFN.com
Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2... - br.ADVFN.com
Trinity Biotech stock hits 52-week low at $0.74 amid market challenges - Investing.com
Trinity Biotech reports leap in CGM system accuracy - Investing.com
Trinity Biotech secures US funding for HIV tests - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com
Trinity Biotech announces breakthrough in CGM technology - Investing.com
Trinity Biotech Expands Market Reach with New ADS Offering - Nasdaq
Trinity Biotech advances HIV test manufacturing to offshore site - Investing.com
Trinity Biotech regains Nasdaq compliance - Investing.com
Trinity Biotech invests in rapid sepsis diagnostics firm By Investing.com - Investing.com
Trinity Biotech advances next-gen glucose monitor - Investing.com India
Global Blood Testing Market Size & Outlook, 2024-2030 - Grand View Research
Trinity Biotech to Implement ADS Ratio Change By Investing.com - Investing.com India
The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo - Yahoo Finance
TRIB News Today | Why did Trinity Biotech stock go up today? - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Investors in health-care stocks get rich as M&A booms - MarketWatch
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling - Insider Monkey
Trinity Biotech Plc Adr (TRIB) 財務データ
収益
当期純利益
現金流量
EPS
0.89%
大文字化:
|
ボリューム (24 時間):